Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact email@example.com.
Editor Note: For more information about this release, please scroll to bottom
LONDON, May 20, 2014 /PRNewswire/ --
The US markets saw a positive sentiment on Monday, May 19, 2014, with the NASDAQ Composite closing at 4,125.82, up 0.86%, the Dow Jones Industrial Average ending the session 0.12% higher at 16,511.86, and the S&P 500 edging 0.38% higher to finish the trading session at 1,885.08. During the session gains in the Information Technology, Health Care, and Financials sectors positively impacted the broader market, while some retraction came in from Consumer Staples, Telecommunication Services, and Utilities sectors. A number of stocks saw large movements, including Inovio Pharmaceuticals Inc. (NYSE MKT: INO), Novavax Inc. (NASDAQ: NVAX), FreeSeas Inc. (NASDAQ: FREE) and ImmunoCellular Therapeutics Ltd (NYSE MKT: IMUC). Free technical research on INO, NVAX, FREE and IMUC can be downloaded upon signing up at:
On Monday, Inovio Pharmaceuticals Inc.'s stock fluctuated between $2.12 and $2.30 before ending the session 6.54% higher at $2.28. Inovio Pharmaceuticals Inc.'s stock reported a trading volume of 4.29 million shares, below to its three months average volume of 8.03 million shares. The company's shares have declined 9.52% in the last one month and 21.38% on YTD basis. However, the stock has surged 5.56% in the previous three trading sessions. The S&P 500 Health Care Sector Index registered a gain of 0.64% during the trading session, and it has charted up 2.68% in the last one month. The stock is trading below its 50-day and 200-day moving averages of $2.90 and $2.43, respectively. Moreover, shares of the company have a Relative Strength Index (RSI) of 34.09. Sign up today to read free research on INO at:
Novavax Inc.'s stock finished Monday's session 10.36% higher at $4.58. A total of 5.55 million shares were traded, which was above its three months average volume of 4.62 million shares. The stock moved between $4.14 and $4.63 during the session. Novavax Inc.'s stock has advanced 7.76% in the previous three trading sessions and 13.65% in the last one month. However, from the beginning of 2014, the stock has declined 10.55%. The S&P 500 Health Care Sector Index mapped a gain of 0.64% during the trading session, and the same charted up 0.19% in the last three months. The company's shares are trading above their 50-day and 200-day moving averages. Moreover, the stock's 50-day moving average of $4.45 is greater than its 200-day moving average of $4.14. Novavax Inc.'s stock has an RSI of 47.31. Sign up today to read free research on NVAX at:
FreeSeas Inc.'s stock rallied 16.67%, closing the day at $1.33. The stock recorded a trading volume of 3.52 million shares, much above its three months average volume of 0.97 million shares. The stock oscillated between $1.10 and $1.45 during the trading session. Over the past three trading sessions and over the last one month, FreeSeas Inc.'s shares have advanced 14.66% and 2.31%, respectively. However, the stock has lost 44.12% since the beginning of 2014. The S&P 500 Industrials Sector Index reported a gain of 0.39% during the trading session and charted up 4.70% in the last three months. The stock is trading below its 50-day and 200-day moving averages of $1.48 and $1.71, respectively. Additionally, the stock has an RSI of 33.32. Sign up today to read free research on FREE at:
On Monday, shares in ImmunoCellular Therapeutics Ltd recorded a trading volume of 2.25 million shares, higher than its three months average volume of 1.09 million shares. The stock ended the day at $1.29, which was 10.26% above its previous day's closing, and registered an intraday range of $1.16 and $1.29. ImmunoCellular Therapeutics Ltd's shares have surged 7.50% in the previous three trading sessions and 8.40% in the last one month. Additionally, from the beginning of 2014, the stock has gained an upside of 39.46%. The S&P 500 Health Care Sector Index mapped a gain of 0.64% during the trading session, and the index has charted up 2.68% in the last one month. The company's shares are trading above their 50-day moving average of $1.23 while the 50-day moving average is below the stock's 200-day moving average of $1.94. Furthermore, shares of the company have an RSI of 46.98. Sign up today to read free research on IMUC at:
1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.
2. Information in this release is produced on a best efforts basis by Rohit Tuli, a CFA charterholder. The content is then further fact checked and reviewed by an outsourced research provider. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.
3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.
4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco [at] http://www.investor-edge.com.
5. For any urgent concerns or inquiries, please contact us at compliance [at] http://www.investor-edge.com.
6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research [at] http://www.investor-edge.com for consideration.
Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Investor-Edge, represented by Rohit Tuli, CFA. An outsourced research services provider has only reviewed the information provided by Investor-Edge in this article or report according to the procedures outlined by Investor-Edge. Investor-Edge is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.
NOT FINANCIAL ADVICE
Investor-Edge makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.
NO WARRANTY OR LIABILITY ASSUMED
Investor-Edge is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Investor-Edge whatsoever for any direct, indirect or consequential loss arising from the use of this document. Investor-Edge expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Investor-Edge does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
©2012 PR Newswire. All Rights Reserved.